논문KCI 등재
Erratum to ‘Systemic therapy in advanced hepatocellular carcinoma’ [Clin Mol Hepatol 2023;29:516-519]
0
조회
0
다운로드
0
인용
0
참고문헌
관련 논문AI추천
Erratum to ‘Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial’ [Clin Mol Hepatol 2024;30:807-823]Ahmed O. Kaseb, Bohwa Sohn, Hyewon Park, Ju-Seog Lee, Kena Park, Michael A. Curran, Sang Hee Kang, Seung-Woo Baek, Sung Hwan Lee, Sun-Hee Leem, Sunyoung S. Lee, Sun Young Yim, Young Nyun Park, Yun Seong Jeong대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Erratum to ‘Evolutionary changes in metabolic dysfunction- associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study’ [Clin Mol Hepatol 2024;30:487-499]Dong Hyeon Lee, Gyeongsil Lee, Heejoon Jang, Hye Jun Kim, Joseph C Ahn, Joung Sik Son, Lei Chen, Meng Sha, Sang Min Park, Seogsong Jeong, Seulggie Choi, Sun Jae Park, Won Kim, Yun Hwan Oh대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제3호Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]Dong Hyun Sinn, Joo Hyun Oh대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]Byung Seok Lee, Eun Sun Jang, Hye Jung Park, In Hee Kim, Kyung-Ah Kim, Sang Hoon Ahn, Sejoon Lee, Seungtaek Kim, Sook Hyang Jeong, Sung Bum Cho, Woo Jin Chung, Young Seok Kim, Youn Jae Lee대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제3호Erratum to ‘KASL clinical practice guidelines for management of chronic hepatitis B’ [Clin Mol Hepatol 2022;28:276-331]The Korean Association for the Study of the Liver (KASL)대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호Systemic therapy in advanced hepatocellular carcinomaJoseph C Ahn, Ju Dong Yang, Nguyen H. Tran대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호
이 간행물의 다른 논문 (36건)
Current burden of MASLD, MetALD, and hepatic fibrosis among US adults with prediabetes and diabetes, 2017–2023Rohit Loomba, Aijaz Ahmed, Donghee Kimpp. 235-238What is new in the 2024 Chinese guidelines for fatty liver disease?Rui-Xu Yang, Jian-Gao Fan, Vincent Wai-Sun Wongpp. 239-246Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”Chih-Cheng Lai, Po-Yu Huang, Chi-Kuei Hsupp. 247-248Classification of microvascular invasion of hepatocellular carcinoma: Different standards, common goals: Letter to the editor on “Classification of microvascular invasion of hepatocellular carcinoma: Correlation with prognosis and magnetic resonance imaging”Weiwei Shi, Hang Jiang, Yihui Rong, Tianshi Ma, Wei Chen, Wei Chenpp. 249-251Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction- associated steatotic liver disease and cirrhosis”Weixiong Zhu, Xuefan Zeng, Zengxi Yang, Yusheng Cheng, Wence Zhoupp. 252-253